Cyclophosphamide cystitis in mice: Behavioural characterisation and correlation with bladder inflammation

European Journal of Pain

Volumn 3, Issue 2, 1999, Pages 141-149

  Olivar, Teresa ^a   Laird, Jennifer M A ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Behavioural study; Bladder; Cyclophosphamide; Mice; Visceral pain

Indexed keywords

CYCLOPHOSPHAMIDE; EVANS BLUE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BLEEDING; CONTROLLED STUDY; CYSTITIS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; URINARY EXCRETION; VISCERAL PAIN; WRITHING TEST;

EID: 0033028976     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1053/eujp.1998.0105     Document Type: Article

References (22)

1. Bon K., Lantéri-Minet M., de Pommery J., Michiels J. F., Menétrey D. Cyclophosphamide cystitis as a model of visceral pain in rats: a survey of hindbrain structures involved in visceroception and nociception using the expression of c-Fos and Krox-24 proteins. Exp Brain Res. 108: 1996;04-416.
2. Bon K., Lantéri-Minet M., de Pommery J., Michiels J. F., Menétrey D. Cyclophosphamide cystitis as a model of visceral pain in rats: minor effects at mesodiencephalic levels as revealed by the expression of c-fos, with a note on Krox-24. Exp Brain Res. 113: 1997;49-264.
3. Cao Y. Q., Mantyh P. W., Carlson E. J., Gillespie A-M., Epstein C. J., Basbaum A. I. Primary afferent tachykinins are required to experience moderate to intense pain. Nature. 392: 1998;90-394.
4. Cox P. J. Cyclophosphamide cystitis: identification of acrolein as the causative agent. Biochem Pharmacol. 28: 1979;045-2049.
5. De Felipe C., Herrero J-F., O'Brian J. A., Palmer J. A., Doyle C. A., Smith A. J. H., Laird J. M. A., Belmonte C., Cervero F., Hunt S. P. Altered nociception, analgesia and aggression in mice lacking the substance P receptor. Nature. 392: 1998;94-397.
6. Fraiser L. H., Kehrer J. P. Murine strain differences in metabolism and bladder toxicity of cyclophosphamide. Toxicology. 75: 1992;57-272.
7. Fraiser L. H., Kehrer J. P. Effect of indomethacin, aspirin, nordihydroguairectic acid and piperonyl butoxide on cyclophosphamide-induced bladder damage. Drug Chem Toxicol. 16: 1993;17-133.
8. Fraiser L. H., Kanekal S., Kehrer J. P. Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs. 42: 1991;81-795.
9. Giamberardino M. A., Vecchiet L., Albe-Fessard D. Comparison of the effects of ureteral calculosis and occlusion on muscular sensitivity to painful stimulation in rats. Pain. 43: 1990;27-234.
10. Giamberardino M. A., Valente R., de Bigontina P., Vecchiet L. Artificial ureteral calculosis in rats: behavioural characterisation of visceral pain episodes and their relationship with referred lumbar muscle hyperalgesia. Pain. 61: 1995;59-469.
11. Herrero J-F., Parrado A., Cervero F. Central and peripheral actions of the NSAID ketoprofen on spinal cord nociceptive reflexes. Neuropharmacology. 36: 1997;425-1431.
12. Kanekal S., Fraiser L., Kehrer J. P. Pharmacokinetics, metabolic activation, and lung toxicity of cyclophosphamide in C57/B16 and ICR mice. Toxicol Appl Pharmacol. 114: 1992.
13. Lantéri-Minet M., Bon K., de Pommery J., Michiels J. F., Menétrey D. Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins. Exp Brain Res. 105: 1995;20-232.
14. Madle E., Korte A., Beek B. Species differences in mutagenicity testing. II. Sister-chromatid exchange and micronucleus induction in rats, mice and Chinese hamsters treated with cyclophosphamide. Mutagenesis. 1: 1986;19-422.
15. Maggi C. A., Lecci A., Santicioli P., Del Bianco E., Giuliani S. Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents. J Auton Nerv Syst. 38: 1992;01-208.
16. Malmberg A. B., Chen C., Tonegawa S., Basbaum A. I. Preserved acute pain and reduced neuropathic pain in mice lacking PKC γ Science. 278: 1997;79-283.
17. Mathes H. W. D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B. P., Kieffer B. L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature. 383: 1996;19-823.
18. Ness T. J., Gebhart G. J. Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterisation of puesdo affective reflexes in the rat. Brain Res. 450: 1988;53-169.
19. Ness T. J., Gebhart G. J. Visceral pain: a review of experimental studies. Pain. 41: 1990;67-234.
20. Simonin F., Valverde O., Smadja C., Slowe S., Kitchen I., Dierich A., Le Meur M., Roques B. P., Maldonado R., Kieffer B. L. Disruption of the kappa-opioid receptor gene enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50, 488H and attentuates morphine withdrawal. EMBO J. 17: 1998;86-897.
21. Vizzard M. A., Erdman S. L., de Groat W. C. Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation. J Comp Neurol. 370: 1996;91-202.
22. Wesselmann U., Czakanski P. P., Affaitati G., Giamberardino M. A. Uterine inflammation as a noxious visceral stimulus: behavioural characterisation in the rat. Neurosci Lett. 246: 1998;3-76.